Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Neximmune Inc
NEXI
Healthcare
Biotechnology
NexImmune, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing an approach to immunotherapy designed to employ the body’s own T cells to generate an immune response that mimics natural biology. Its product candidates include NEXI-001 in acute myeloid leukemia (AML); NEXI-002 in multiple myeloma (MM), and NEXI-003, a solid tumor product candidate for Human...
papillomavirus (HPV) related cancers. The Company provides Artificial Immune Modulation (AIM), which is a nanoparticle technology platform. Its AIM technology enables it to construct nanoparticles that function as synthetic dendritic cells capable of directing a specific T cell-mediated immune response. The AIM nanoparticles employ signaling proteins to deliver instructions to T cells directing a desired immune response. The Company is also developing new AIM nanoparticle constructs and modalities for clinical evaluation in oncology and autoimmune disorders.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (PINL:NEXI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Dec 01, 2023 8:55am
NEXI..... I sold way too soon
Life of a DTer Maddapakka
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 29, 2023 3:50pm
NEXI.....I missed the 1st move to $1.90 but....
Not the 2nd....Cha Ching !!!!!!
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 29, 2023 3:09pm
NEXI.....geez I missed the move to $1.91 from $1.30
I was busy with other things Dang ...looks like all the Front loaders sold at the h.o.d
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 29, 2023 2:44pm
NEXI.....post recent RS getting some "love"
Very tight On watch
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Nov 03, 2023 1:31pm
NEXI.....RS on Oct 19/23 ... 25 : 1 ratio...then this!
Inline XBRL Viewer (sec.gov) ...... previous was this...... Inline XBRL Viewer (sec.gov) ....then previous to that was this..... Inline XBRL Viewer (sec.gov) ......then this .
...more
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 16, 2023 1:56pm
NEXI..... This has turned out to be a typical NASDAQ
P & D No position....never had one Only the Chasers get their heads handed back to them ; ) My condolensces
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 16, 2023 11:05am
NEXI...sorry about this late update but...
If I was ontop of this...... My post would have said that it was in PB mode with support at $0.67....it has to hold and rally or it could be done for the day. Currently at 2x's bottom at $0.62
...more
(69)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 16, 2023 9:00am
NEXI ....early a.m runner on NR
Meeting this evening Past history of big single day volume & price action..... then retraces No position
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth